Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validation

Objectives. A quantitative anti-transcription intermediary factor 1-gamma (anti-TIF1-γ) ELISA may improve the detection of cancer-associated myositis (CAM). The aims of this study were the development and validation of a quantitative anti-TIF1-γ autoantibody ELISA in patients with myositis. Methods....

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Aggarwal, Rohit, Oddis, Chester V., Goudeau, Danielle, Fertig, Noreen, Metes, Ilinca, Stephens, Chad, Qi, Zengbiao, Koontz, Diane, Levesque, Marc C.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2014
Assuntos:
Basic Science
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3930887/
https://ncbi.nlm.nih.gov/pubmed/24255164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/ket383
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares